Detalhe da pesquisa
1.
Interferon-γ Drives Treg Fragility to Promote Anti-tumor Immunity.
Cell
; 169(6): 1130-1141.e11, 2017 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28552348
2.
The Tumor Microenvironment Represses T Cell Mitochondrial Biogenesis to Drive Intratumoral T Cell Metabolic Insufficiency and Dysfunction.
Immunity
; 45(2): 374-88, 2016 08 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-27496732
3.
The Tumor Microenvironment Represses T Cell Mitochondrial Biogenesis to Drive Intratumoral T Cell Metabolic Insufficiency and Dysfunction.
Immunity
; 45(3): 701-703, 2016 09 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-27653602
4.
Regulatory T Cells in the Tumor Microenvironment.
Adv Exp Med Biol
; 1273: 105-134, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33119878
5.
Radiomic analysis of patient and inter-organ heterogeneity in response to immunotherapies and BRAF targeted therapy in metastatic melanoma.
medRxiv
; 2024 Apr 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38712112
6.
Partial tumor irradiation plus pembrolizumab in treating large advanced solid tumor metastases.
J Clin Invest
; 133(10)2023 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37183819
7.
Tumor cell p38 inhibition to overcome immunotherapy resistance.
Res Sq
; 2023 Aug 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37645831
8.
Regulatory T Cell-Derived TRAIL Is Not Required for Peripheral Tolerance.
Immunohorizons
; 5(1): 48-58, 2021 01 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-33483333